Gene: SRD5A1 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 Biomarker group CTD_human Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. 20564326 2010
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 GeneticVariation group LHGDN VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. 18483391 2008
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 Biomarker group CTD_human [Dutasteride in the treatment of hormone refractory prostate cancer]. 18500220 2008
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 Biomarker group RGD Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. 16818707 2006
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 AlteredExpression group LHGDN Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. 15543614 2005
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 AlteredExpression group LHGDN Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. 15538746 2005
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 AlteredExpression group LHGDN The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis. 12738739 2003